Dermatology WEBINAR: Principles and Practice Strategies in Primary Care

CME : 20
Conference Summary

Dermatology WEBINAR: Principles and Practice Strategies in Primary Care is organized by American Medical Seminars (AMS), Inc. and will be held from May 10 - 13, 2021. This Course has been approved for a maximum of 20 AMA PRA Category 1 Credits™.

WEBINAR SALE: Save 50% on a future live streaming webinar! Register for a Live Streaming Webinar before 1/31/2021 and get 50% off of a future live streaming webinar in 2021. Use Promotion Code BOGO50 when you register and we will email you your 50% off Webinar voucher

Narrative Description:
Following this course, the participant should be able to appraise the various etiologies for basic cutaneous lesions; distinguish the characteristics of commonly seen skin disorders and develop an appropriate differential that leads to the most probable diagnosis; apply a treatment plan and follow-up procedure that will enable the practicing physician to effectively treat many disorders. This activity is expected to result in improved competence in making appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

The emphasis will be based on generally accepted standards and consensus, including evidence-based guidelines and reputable position statements where available, with a focus on recommendations for diagnosis, treatment, and when to refer. Since dermatologic problems often reveal systemic disorders, and the skin is the largest and most accessible “organ”, this course was designed as a review and update for practicing physicians and is applicable to most specialties.

Specific Objectives:
Day 1
Introduction - Essentials of Dermatology Terminology and Diagnosis.

Upon completion of this session, the participant should be able to: COMP
• Institute universal dermatologic terminology to facilitate optimal interdepartmental continuity of care.
• Approach dermatologic disorders with a consistent and logical method.
• Apply common diagnostic modalities, including light, dermoscopy, photography, telemedicine, and microscopy to aid in dermatologic diagnoses.

A Field Trip to the Pharmacy - OTC Therapies Accessible to Everyone
Upon completion of this session, the participant should be able to: COMP
• Detangle the labels of common OTC topicals.
• Recommend simple but effective skin care regimens for common issues like dry skin, antiaging, and pruritus.
• Dispel myths about popular and widely-advertised OTC subscription products.

Dermatitis. 
Upon completion of this session, the participant should be able to: GL, COMP
• Distinguish between types of intrinsic and extrinsic dermatitis, including contact, atopic, stasis, and seborrheic dermatitis.
• Plan the testing for identification of allergens in contact dermatitis, including poison ivy and common household and workplace contact allergens.
• Develop prevention and treatment plans for various types of dermatitis based on recent AAD guidelines, particularly for atopic dermatitis.

Sunlight and its Effects, Part I: Solar Radiation, Photodamage, Photosensitivity Reactions, and Actinic Keratosis.
Upon completion of this session, the participant should be able to: COMP, EBM, GL
• Acquire a basic understanding of both therapeutic and harmful effects of ultraviolet radiation in dermatology based on recent literature.
• Recognize common photosensitivity disorders, and develop an approach to diagnosis and treatment of these conditions.
• Gain a clinical understanding of the diagnosis of actinic keratosis and approach to “lesion” vs. “field” therapy based on latest evidence-based guidelines.

Sunlight and its Effects, Part II: Non-Melanoma Skin Cancers and Sun Protection.
Upon completion of this session, the participant should be able to: COMP, EBM
• Identify clinical features of non-melanoma skin cancer and develop treatment (including Mohs surgery) and follow-up approaches to these lesions.
• Demonstrate increased awareness of the incidence and associated morbidity with NMSC in transplant • patients, particularly with reference to squamous cell carcinoma and its updated staging and management, and facilitate appropriate skin cancer screenings.
• Outline appropriate sun protective measures for your patients as per FDA standards and American •Academy of Dermatology (AAD) recommendations and decode sunscreen safety data from the media.

Day 2
Common Benign Tumors, Part I: Warts, Mollusca, Fibrous Tumors, Cutaneous Horns

Upon completion of this session, the participant should be able to: GL, COMP
• Devise a treatment plan for common tumors, which may include observation, biopsy, removal, and referral.
• Recognize the multiple cutaneous manifestations of warts and “wart-like” lesions and develop a stepwise treatment approach based on literature review and recent guidelines.
• Employ data-driven scripts for patients about observation versus active treatment of benign tumors with self-limited natural histories.

Common Benign Tumors, Part II: Cysts, Vascular Tumors, Dermatofibromas, Keratoses, Lipomas, Soft Tissue Growths, Granulomas
Upon completion of this session, the participant should be able to: EBM, GL, COMP
• Develop an approach to common dermal tumors, including most appropriate type of biopsy or excision based on pathophysiology.
• Initiate systemic evaluation in setting of certain skin lesions that may be associated with underlying medical conditions.
• Demonstrate awareness of guidelines and implementation and/or appropriate referral for managing infantile hemangiomas as per the American Academy of Pediatrics.

Drug Eruptions: Etiology, Differential Diagnosis and Treatment.
Upon completion of this session, the participant should be able to: COMP, EBM
• Recognize the numerous eruptions, such as DRESS, SJS and TEN, induced by medications.
• Recognize, identify and avoid the “most common” suspected drugs in producing certain reaction patterns.
• Employ workup and treatment of DRESS and other severe drug reactions.

Other Inflammatory Eruptions: Lichenoid, Pityriasiform, Granulomatous, Blistering, and Urticarial.
Upon completion of this session, the participant should be able to: COMP
• Differentiate many types of eruptions including lichen planus, granuloma annulare, pityriasiform dermatoses, blistering disorders, and urticaria.
• Employ diagnostic measures for these rashes, including physical exam, appropriate biopsy type, and laboratory modalities when indicated.
• Develop etiology and symptom-specific treatment regimens to address these eruptions.

Dermatologic Manifestations of Systemic Disease.
Upon completion of this session, the participant should be able to: EBM, GL, COMP
• Identify cutaneous markers of certain systemic diseases.
• Distinguish specific and nonspecific findings in relationship to underlying disease.
• Evaluate pruritus and differentiate those cases associated with systemic disease vs. primary cutaneous disease

Day 3
Psoriasis.

Upon completion of this session, using AAD Guidelines for Psoriasis Therapy, the participant should be able to: EBM, GL, COMP
• Evaluate the spectrum of classical and subtle cutaneous changes of psoriasis.
• Formulate the basic pathophysiology of psoriasis.
• Approach topical psoriasis therapy with a basic algorithm.
• Develop a treatment plan based upon the AAD Guidelines for Management of Psoriasis and Psoriatic • Arthritis and Use of Biologics, Phototherapy and Chemotherapy.

Cutaneous Infections and Infestations, Part !: Bacterial, Viral, and Fungal.
Upon completion of this session, the participant should be able to: COMP, EBM
• Differentiate viral infections like herpes simplex and herpes zoster based on morphology, distribution of lesions, and laboratory testing.
• Determine appropriate treatment and prevention (including vaccination) plans for herpes simplex and herpes zoster as per CDC and FDA recommendations.
• Diagnose bacterial (including MRSA) and fungal infections of the skin and employ first line therapy.

Cutaneous Infections and Infestations, Part II: Parasites, Bites, and Stings.
Upon completion of this session, the participant should be able to: COMP
• Outline key travel history inquiries and diagnostic modalities for patients with parasitic infections and initiate first line therapy
• Speciate arthropods and that commonly cause skin disease like ticks, mites, bed bugs, and stinging insects so that appropriate therapy can be initiated acutely.
• Review preventative measures, including indications and safety of pesticides, and other measures for arthropod assault avoidance.

Malignant Melanoma, Part I.
Upon completion of this session, the participant should be able to: EBM, GL, COMP
• Utilize the ABCDE approach to the description of pigmented lesions and features of melanoma.
Analyze the biology of melanoma.
• Appraise and employ the AAD Guidelines of Care for the Management of Primary Cutaneous Melanoma.
• Refer for a surgical approach, as per the NCCN (National Comprehensive Clinical Network) guidelines for melanoma.

Malignant Melanoma, Other Melanocytic Lesions, and Misc Malignancies, Part II.
Upon completion of this session, the participant should be able to: COMP, GL
• Appraise "dysplastic nevi" and describe the relationship between dysplastic nevi and melanomas.
• Develop an approach to examination, testing and follow up of families with dysplastic nevi and melanomas as per NCCN guidelines.
• Identify benign nevi variants and the risks and benefits of removal based on cosmesis, histopathological report variances, and recurrence.
• Identify rarer malignancies like Merkel cell carcinoma, cutaneous T-cell lymphoma, and angiosarcoma, and • cutaneous metastases with reference to referral recommendations.

Day 4
Acne, Part I: Pathophysiology, Recognition and Treatment.

Upon completion of this session, using evidence-based guidelines of the AAD, the participant should be able to: EBM, GL, COMP
• Characterize types of acne lesions and determine appropriate therapy based on pathophysiology.
• Develop a therapeutic ladder with a clear understanding of treatment indications, expectations, and side effects.
• Recognize current issues regarding usage of isotretinoin and long-term oral antibiotics to include the AAD • Guidelines for prescribing isotretinoin in females of childbearing potential.

Acne, Part II: Identification and Treatment of Acne, Acneiform Eruptions, and Rosacea.
Upon completion of this session, the participant should be able to: COMP, EBM
• Recognize various acneiform eruptions to include post-adolescent acne, periorificial dermatitis, folliculitis, hidradenitis, and rosacea.
• Analyze physical findings and testing results to distinguish such conditions, including culture and biopsy when appropriate, and initiate therapy.
• Diagnose and treat rosacea and consider possible systemic associations as per published evidence.

Disorders of Hair and Nails.
Upon completion of this session, the participant should be able to: GL, COMP
• Develop an objective, simplified approach to hair loss and its common triggers per AAD recommendations
• Determine the common causes of nail dystrophy by applying the AAD recommended diagnostic algorithm.
• Formulate a treatment strategy for nail fold inflammation.

Dermatologic Inpatient Consults:
Upon completion of this session, the participant should be able to: COMP
• Quickly diagnose common skin findings in inpatients, like stasis dermatitis, graft-versus-host disease, and drug reactions.
• Determine a workflow for ‘dermatologic emergencies’.
• Utilize appropriate lexicon, clinical descriptions, and acuity of cutaneous eruptions to arrive at an efficient primary care/dermatology team approach to inpatients.

Review Cases for the Week:
Upon completion of this session, the participant should be able to: COMP
• Apply the breadth of management pearls covered over these 5 days to common dermatologic cases that present in primary care.
• Implement a few basic procedural modalities (like biopsies and KOH), topical office-based therapies (like for warts), and surveillance measures (like quality photography) into routine primary care practice.
• Develop a strong communicative relationship with dermatology and dermatopathology in a primary care region for comprehensive patient care and consider telemedicine as a touchpoint.

Credit Info

  • CME : 20
Specialties

  • Dermatology
  • Primary Care

Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat

Reviews Given by People

Browse CME / CE Conferences by Specialty   View All